|
|
|
|
Shanghai DND Pharm-Technology Co.,Ltd.
|
Febuxostat
Febuxostat
Jun 15, 2009 5:49:51 PM
CAS NO.144060-53-7
Appearance Off-white crystall powder
Water NMT1.0%
Residue on ignition NMT 0.1%
Heavy metals NMT 20ppm
Purity(HPLC) NLT 99%
Febuxostat, a novel, nonpurine, selective inhibitor of xanthine oxidase, is effective for the treatment of gout and hyperuricemia.It was approved by the european medicines agency on april 21, 2008.